Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00082095
What this trial is testing

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Who this might be right for
Metastatic Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62
Post-approval studies (Phase 4)Study completedNCT00796692
What this trial is testing

Nadroparin for the Initial Treatment of Pulmonary Thromboembolism

Who this might be right for
Pulmonary EmbolismThromboembolismVascular Diseases+1 more
Beijing Chao Yang Hospital 274
Not applicableStudy completedNCT02143739
What this trial is testing

The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China

Who this might be right for
Asthma
AstraZeneca 4,817
Testing effectiveness (Phase 2)UnknownNCT05668767
What this trial is testing

Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Beijing Chest Hospital 20
Large-scale testing (Phase 3)Study completedNCT03856411
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Who this might be right for
Treatment-naive Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 465
Not applicableStudy completedNCT03919760
What this trial is testing

Early Psychosis Intervention - Spreading Evidence-based Treatment

Who this might be right for
First Episode PsychosisSchizophrenia, ChildhoodPsychosis+7 more
Centre for Addiction and Mental Health 100
Testing effectiveness (Phase 2)Study completedNCT00462423
What this trial is testing

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

Who this might be right for
Metastatic Malignant Melanoma
Lynn E. Spitler, MD 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT06200779
What this trial is testing

Tailored Vs. Empirical Helicobacter Pylori Infection Treatment

Who this might be right for
Helicobacter Pylori Infection
Manuel Coelho da Rocha 160
Not applicableStudy completedNCT03102788
What this trial is testing

Task Shifting in the Care for Patients With Hand Osteoarthritis

Who this might be right for
Osteoarthritis Both Hands
National Resource Center for Rehabilitation in Rheumatology 400
Large-scale testing (Phase 3)Looking for participantsNCT07472517
What this trial is testing

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer (SCLC)Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim 670
Large-scale testing (Phase 3)Study completedNCT02466490
What this trial is testing

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Stendhal Americas, S.A. 272
Testing effectiveness (Phase 2)Study completedNCT02659059
What this trial is testing

Nivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Bristol-Myers Squibb 324
Testing effectiveness (Phase 2)UnknownNCT05795296
What this trial is testing

Efficacy and Safety of Fruquintinib With Sintilimab as First-line Therapy in Gastric Cancer

Who this might be right for
Stomach Neoplasms
RenJi Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07822542
What this trial is testing

A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jiangsu Hansoh Pharmaceutical Co., Ltd. 448
Testing effectiveness (Phase 2)Study completedNCT00274469
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 205
Large-scale testing (Phase 3)Study completedNCT00390442
What this trial is testing

Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema

Who this might be right for
Cardiogenic Pulmonary Edema
Hopital Lariboisière
Post-approval studies (Phase 4)Not Yet RecruitingNCT07302841
What this trial is testing

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Tianjin Medical University Cancer Institute and Hospital 28
Not applicableStudy completedNCT01892605
What this trial is testing

The Clinical Application and Mechanism of Music Therapy (Mozart's Effect) on Epilepsy

Who this might be right for
Seizure
Kaohsiung Medical University Chung-Ho Memorial Hospital 46
Testing effectiveness (Phase 2)Study completedNCT00503906
What this trial is testing

Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Miami 30
Large-scale testing (Phase 3)Ended earlyNCT02129699
What this trial is testing

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy

Who this might be right for
Lung Cancer Non-small Cell Stage IV
ETOP IBCSG Partners Foundation 595
Next Page